HAVCR2 and neoplasm: Notably, while PD-1 but not Tim-3 blockade significantly decreased tumor burden and increased survival, dual PD-1 and Tim-3 blockade was the most potent therapy at decreasing tumor growth and prolonging survival of mice with YUMMER 1.7 melanoma (Supplemental Figure 5, A–C).